Literature DB >> 17597195

Dorsal root ganglionectomy for the diagnosis of sensory neuropathies. Surgical technique and results.

Benedicto Oscar Colli1, Carlos Gilberto Carlotti, João Alberto Assirati, Luiza da Silva Lopes, Wilson Marques, Leila Chimelli, Luciano Neder, Amilton Antunes Barreira.   

Abstract

BACKGROUND: Inflammatory diseases stand out among sensory neuronopathies because, in their active phase, they can be treated with immunosuppressive agents. Immunosuppressive therapy may present severe adverse effects and requires previous inflammatory activity confirmation. Sensory neuronopathies are diagnosed based on clinical and EMG findings. Diagnostic confirmation and identification of inflammatory activity are based on sensory ganglion histopathological examination. We describe the surgical technique used for dorsal root ganglionectomy in patients with clinical/EMG diagnosis of sensory neuronopathies.
METHODS: The sensory ganglion was obtained from 15 patients through a small T7-T8 hemilaminectomy and foraminotomy to expose the C7 root from its origin to the spinal nerve bifurcation. In 6 patients, the dural cuff supposed to contain the ganglion was resected en bloc; and in 9 patients, the ganglion was obtained through a longitudinal incision of the dural cuff and microsurgical dissection from the ventral and dorsal roots and radicular arteries. All ganglia were histopathologically examined.
RESULTS: No ganglion was found in the dural cuff in 2 patients submitted to en bloc removal, and the ganglion was removed in all patients who underwent microsurgical dissection. All but 2 patients that had ganglion examination presented a neuronopathy of nerve cell loss, 3 with mononuclear inflammatory infiltrate. These patients underwent immunosuppressive therapy, and 2 of them presented clinical improvement. No surgical complications were observed.
CONCLUSIONS: Microsurgical dorsal root ganglionectomy for diagnosing inflammatory sensory ganglionopathies was effective and safe. Although safe, en bloc resection of the proximal dural cuff was not effective for this purpose.

Entities:  

Mesh:

Year:  2007        PMID: 17597195     DOI: 10.1016/j.surneu.2007.01.057

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

Review 1.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

2.  Sensory neuronopathy involves the spinal cord and brachial plexus: a quantitative study employing multiple-echo data image combination (MEDIC) and turbo inversion recovery magnitude (TIRM).

Authors:  Yi-Fang Bao; Wei-Jun Tang; Dong-Qing Zhu; Yu-Xin Li; Chi-Shing Zee; Xiang-Jun Chen; Dao-Ying Geng
Journal:  Neuroradiology       Date:  2012-08-26       Impact factor: 2.804

3.  Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study.

Authors:  Jean-Christophe Antoine; Florence Robert-Varvat; Thierry Maisonobe; Alain Créange; Jérôme Franques; Stéphane Mathis; Emilien Delmont; Thierry Kuntzer; Jean-Pascal Lefaucheur; Jean Pouget; Karine Viala; Claude Desnuelle; Andoni Echaniz-Laguna; Francesco Rotolo; Jean-Philippe Camdessanché
Journal:  J Neurol       Date:  2014-08-10       Impact factor: 4.849

4.  Sensory neuronopathy and autoimmune diseases.

Authors:  Alberto R M Martinez; Marcelo B Nunes; Anamarli Nucci; Marcondes C França
Journal:  Autoimmune Dis       Date:  2012-01-19

5.  Sjögren Sensory Neuronopathy (Sjögren Ganglionopathy): Long-Term Outcome and Treatment Response in a Series of 13 Cases.

Authors:  P Ricardo Pereira; Karine Viala; Thierry Maisonobe; Julien Haroche; Alexis Mathian; Miguel Hié; Zahir Amoura; Fleur Cohen Aubart
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

6.  The pattern and diagnostic criteria of sensory neuronopathy: a case-control study.

Authors:  Jean-Philippe Camdessanché; Guillemette Jousserand; Karine Ferraud; Christophe Vial; Philippe Petiot; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.